亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

湖北鑫源順醫藥化工有限公司  

沒有填寫主營業務~~

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:梁雨瑤
  • 電話:18062412635
  • QQ:1985589312
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 泰洛龍/泰洛倫27591-97-5
泰洛龍/泰洛倫27591-97-5
單價 100.00 / kg對比
銷量 暫無
發貨 湖北武漢市付款后24小時內
庫存 5000kg起訂1kg
品牌 鑫源順
型號 USP/BP/EP/CP
規格 99%
過期 長期有效
更新 2012-09-11 16:08
 
詳細信息
泰洛龍/泰洛倫27591-97-5
CAS號: 27591-97-5
分子式: C25H34N2O3
分子量: 410.5491 
外觀:橙黃色結晶粉末
含量:99%
熔點:232-234 °C
包裝:1kg,5kg,25kg/桶
用途:醫藥原料
(S,S)-2,8-二氮雜二環[4,3,0]壬烷151213-42-2
CAS號151213-42-2
分子式: C7H16Cl2N2
中文別名:莫西沙星側鏈對映體
英文名稱:(R,R)-2,8-Diazabicyclo[4,3,0]nonane
CAS號:147459-51-6
分子式:C7H14N2
分子量:126.16
性狀:無色至棕色油狀液體或粘稠液體
含量(GC):≥99.5%
比旋度:+2°~+3°
水分:≤0.5%
標準:企業標準
包裝規格:5公斤鋁聽。
用途:莫西沙星中間體
©2025 湖北鑫源順醫藥化工有限公司 版權所有   技術支持:化工網   訪問量:6236  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |